FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


14853 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Physical science technician Physics technician
Physiological jaundice (& [NOS]) Newborn physiological jaundice
Physostigmine 0.25% eye drops Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter conventional release eye solution (clinical drug)
Physostigmine 0.5% eye drops Product containing precisely physostigmine salicylate 5 milligram/1 milliliter conventional release eye solution (clinical drug)
Physostigmine+pilocarpine 0.25%+2% eye drops Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution
Physostigmine+pilocarpine 0.25%+4% eye drops Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug)
Physostigmine+pilocarpine 0.5%+4% eye drops Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug)
Pichia ohmeri Kodamaea ohmeri (organism)
Pick's cell Niemann-Pick cell
Picornavirus Family Picornaviridae (organism)
Pigeon droppings protein Pigeon droppings
Pigmentierter Nävus Pigmented nevus
Pigmented skin lesion of suspected malignant nature Suspected malignant pigmented skin lesion (situation)
Pilocarpine hydrochloride 10% eye drops Product containing precisely pilocarpine hydrochloride 100 milligram/1 milliliter conventional release eye solution (clinical drug)
Pilocarpine hydrochloride 5.0mg tablet Product containing precisely pilocarpine hydrochloride 5 milligram/1 each conventional release oral tablet (clinical drug)
Pilocarpine nitrate 1% conventional release eye drops Product containing only pilocarpine in ocular dose form (medicinal product form)
Pilocarpine nitrate 1% single-use eye drops Product containing only pilocarpine in ocular dose form (medicinal product form)
Pilocarpine nitrate 2% conventional release eye drops Product containing only pilocarpine in ocular dose form (medicinal product form)
Pilocarpine nitrate 2% single-use eye drops Product containing only pilocarpine in ocular dose form (medicinal product form)
Pilocarpine nitrate 4% conventional release eye drops Product containing only pilocarpine in ocular dose form (medicinal product form)
Pilocarpine nitrate 4% single-use eye drops Product containing only pilocarpine in ocular dose form (medicinal product form)
Pilocarpine nitrate 4% single-use eye drops Product containing only pilocarpine in ocular dose form (medicinal product form)
Pilocytic astrocytoma Pilocytic astrocytoma
Pilonidal cyst with no abscess Pilonidal cyst
Pioglitazone 15mg + metformin 1g m/r tablet Metformin and pioglitazone only product in oral dose form
Pioglitazone 15mg + metformin 1g prolonged-release oral tablet Metformin and pioglitazone only product in oral dose form
Pioglitazone 30mg + metformin 1g m/r tablet Metformin and pioglitazone only product in oral dose form
Pioglitazone 30mg + metformin 1g prolonged-release oral tablet Metformin and pioglitazone only product in oral dose form
pipéracilline 1 g, fiole de poudre pour solution injectable Product containing precisely piperacillin anhydrous (as piperacillin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)
pipéracilline 2 g, fiole de poudre pour solution injectable Piperacillin anhydrous (as piperacillin sodium) 2 g powder for solution for injection vial
Piperacillin 3g injection (pdr for recon) Piperacillin anhydrous (as piperacillin sodium) 3 g powder for solution for injection vial
Piperacillin 4g infusion set Piperacillin anhydrous (as piperacillin sodium) 4 g powder for solution for injection vial
pipéracilline 4 g, fiole de poudre pour solution injectable Piperacillin anhydrous (as piperacillin sodium) 4 g powder for solution for injection vial
pipéracilline 4 g/tazobactam 500 mg, fiole de poudre et solvant pour perfusion Product containing precisely piperacillin (as piperacillin sodium) 4 gram and tazobactam (as tazobactam sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)
Piperacillin sodium + tazobactam sodium ns/ns injection Product containing piperacillin and tazobactam (medicinal product)
Piperacillin sodium 3g powder for injection solution vial Piperacillin anhydrous (as piperacillin sodium) 3 g powder for solution for injection vial
Piperacillin sodium 4g powder for injection solution vial Piperacillin anhydrous (as piperacillin sodium) 4 g powder for solution for injection vial
Piperazine+sennosides 4g/15.3mg/sachet oral powder Product containing only piperazine and sennoside (medicinal product)
Piperidolate hydrochloride adverse reaction Adverse reaction to piperidolate (disorder)
Piple cumanesis cumanesis Aburria cumanensis subspecies cumanensis (organism)
Pirbuterol acetate 0.2mg aerosol Product containing only pirbuterol (medicinal product)
Piringer's lymphadenitis Lymphadenitis caused by Toxoplasma gondii (disorder)
Piringer-Kuchinka's syndrome Lymphadenitis caused by Toxoplasma gondii (disorder)
Piringer-Kuchinka's syndrome Lymphadenitis caused by Toxoplasma gondii (disorder)
Piroxicam 10mg dispersible tablet Piroxicam 10 mg oral tablet
Piroxicam 20mg conventional release orodispersible tablet Piroxicam 20 mg oral tablet
Piroxicam 20mg dispersible tablet Piroxicam 20 mg oral tablet
Piroxicam 20mg melt tablet Piroxicam 20 mg oral tablet
Pitt Hopkins-like syndrome CNTNAP2-related developmental and epileptic encephalopathy
Pituitary adenoma, no International Classification of Diseases for Oncology subtype Benign pituitary adenoma (morphologic abnormality)
Pituitary hypothyroidism Secondary hypothyroidism
Pituitary interstitial cell stimulating hormone Pituitary luteinizing hormone
Pityriasis lichenoides chronica Chronic lichenoid pityriasis
Pityriasis lichenoides et varioliformis acuta Acute lichenoid pityriasis
Pityriasis lichenoides et varioliformis of Mucha-Habermann Acute lichenoid pityriasis
Pityrosporum folliculitis Malassezia folliculitis (disorder)
Pityrosporum infection of skin Malassezia infection of skin (disorder)
Pizotifen 250micrograms/5mL elixir Product containing precisely pizotifen 50 microgram/1 milliliter conventional release oral solution (clinical drug)
Placement Insertion - action (qualifier value)
Placement of prosthesis in organ NOC Implantation procedure (procedure)
Placement of prosthesis in organ NOC NOS Implantation procedure (procedure)
Placement of prosthesis in organ NOC OS Implantation procedure (procedure)
Placenta normal size Placental volume within reference range
Placental abnormality, antepartum Placental finding
Placental polyp - delivered with postnatal complication Placental polyp with postnatal complication
Plain X-ray ribs abnormal Plain X-ray of bone structure of rib abnormal (finding)
Plain X-ray ribs normal Plain X-ray of bone structure of rib normal
Planococcus okeanokoites Planomicrobium okeanokoites (organism)
Plant fiber Plant fiber
Plasma cell leukemia Plasma cell leukemia
Plasma cell myeloma - category Plasma cell myeloma
Plasma factor V level Clotting factor V assay
Plasma factor V level Clotting factor V assay
Plasma kallikrein Kallikrein
Plasmacytoma - category Plasmacytoma
Plasmin activator Plasminogen activator
Plasminogen activator Plasminogen activator
Plasminogen inactivator Plasminogen activator inhibitor
Plastic repair of cranium NOS Reconstruction of cranial defect
Plastic repair of cranium NOS Reconstruction of cranial defect
Plastic repair of organ NOC Surgical repair
Platelet precursor Megakaryocytic cell
Platelet satellite Platelet satellite
syndrome des plaquettes Québec Pseudo von Willebrand disease
Play psychotherapy Play therapy
Pleura endoscopy Thoracoscopy
Pleural effusion associated with pancreatitis Pleural effusion due to pancreatitis (disorder)
Plum - dietary Plum (substance)
Pneumoconiosis due to silicates Pneumoconiosis caused by silicate (disorder)
Pneumocystis carinii DNA Pneumocystis jirovecii DNA
Pneumocystis carinii DNA assay Pneumocystis jirovecii deoxyribonucleic acid assay (procedure)
Pneumocystis carinii IF Pneumocystis jirovecii immunofluorescence (procedure)
Pneumocystis carinii IF Pneumocystis jirovecii immunofluorescence (procedure)
Pneumocystis carinii antigen Pneumocystis jirovecii antigen
Pneumocystis carinii antigen assay Pneumocystis jirovecii antigen assay (procedure)
Pneumocystis carinii antigen level Pneumocystis jirovecii antigen assay (procedure)
Pneumocystis carinii antigen level Pneumocystis jirovecii antigen assay (procedure)
Pneumocystis carinii antigen level Pneumocystis jirovecii antigen assay (procedure)
choroïdite à Pneumocystis carinii Pneumocystis jirovecii choroiditis
Pneumocystis carinii immunofluorescence Pneumocystis jirovecii immunofluorescence (procedure)
Podophyllin 10% Podophyllum resin (substance)

Start Previous Page 89 of 149 Next End


Reference Sets

Reference set descriptor

Back to Start